Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PVC/DEHP Public Health Notice Offers Alternatives For High-Risk Procedures

This article was originally published in The Gray Sheet

Executive Summary

FDA has followed recommendations from Health Care Without Harm by listing several alternatives to PVC/DEHP devices for high-risk procedures, as well as an informational website, in a July 12 public health notification issued to health provider groups

You may also be interested in...



New Business Opportunities For DEHP-Free Products? B Braun Thinks So

Intravenous delivery product manufacturer B Braun is looking to gain market advantage based on what it sees as mounting recognition of the potential dangers of DEHP - a material that has been used in the manufacture of hospital equipment for decades

New Business Opportunities For DEHP-Free Products? B Braun Thinks So

Intravenous delivery product manufacturer B Braun is looking to gain market advantage based on what it sees as mounting recognition of the potential dangers of DEHP - a material that has been used in the manufacture of hospital equipment for decades

California, Massachusetts Bills Propose Ban On DEHP In Medical Devices

C.R. Bard and Kendall Healthcare's lines of Foley urinary catheters may receive increased exposure in California and Massachusetts if the states pass legislation banning the use of DEHP, a chemical used to soften polyvinyl chloride (PVC) plastic, in medical devices

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016907

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel